The continued use of a new obesity treatment can lead to weight loss of up to 23 per cent and a 94 per cent reduction in ...

Aldosari, M. , Al-Shawi, N. and Al-Sowayan, N. (2024) Therapeutic Potential of Berberine in Type 2 Diabetes: A Short Review.

Semaglutide, a GLP-1 agonist, has been widely studied due to its versatility, efficacy, and ability to address multiple ...

Managing diabetes in older adults in India presents unique challenges due to age-related bodily changes and the prevalence of ...

As Nigeria continues to experience a rising tide in non-communicable diseases, including diabetes, VINCENT KURAUN’s ...

Minimise the chances of your pet suffering from diabetes by being aware of the following crucial information that can save ...

Eton Pharmaceuticals has acquired the US rights to Amglidia, a treatment developed for neonatal diabetes mellitus, from ...

The food additive carrageenan (E 407) can be responsible for the development of chronic inflammatory bowel disease, ulcers, and increased blood sugar levels in animals. DZD researchers have now ...

A new study reveals surprising findings about how babies exposed to gestational diabetes mellitus (GDM) grow during their first year of life.

The drug is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Amglidia® has been approved by the European Medicines Agency (EMA) and is commercially available in EuropeStrong strategic ...